Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …

DPP4/CD26 is a single-pass transmembrane protein with multiple functions on glycemic
control, cell migration and proliferation, and the immune system, among others. It has …

In practicing evidence-based medicine, physicians use the best evidence currently available
on safety and efficacy in making decisions on treatment choices for their patients. During the …

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …

Background Impaired respiratory function remains underrecognized in patients with type 2
diabetes (T2D), despite common pulmonary impairment. Meanwhile, there is little data …

Introduction Type 2 diabetes mellitus (T2DM) is a relevant risk factor for severe forms of
COVID-19 (SARS coronavrus 2 [SARS-CoV-2] disease 2019), and calls for caution because …

Type 2 diabetes mellitus (T2DM) is a widespread metabolic condition with a high global
morbidity and mortality rate that affects the whole body. Their primary consequences are …

BACKGROUND: The coronavirus pandemic has had an extremely negative impact on the
patients with diabetes mellitus (DM both in terms of a more severe course of COVID-19 and …

Актуальность. Пандемия коронавирусной инфекции внесла крайне негативный вклад в
аспекты ведения пациентов с сахарным диабетом (СД), ставших «мишенью» вируса …

Background Glycemic monitoring has become critical during the COVID-19 pandemic
because of poor prognosis in diabetes. Vaccines were key in reducing the spread of …